During the past decade, Delta Research Partners LLC conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 18 clinical trials were completed, i.e. on average, 54.5% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 14 clinical trials were completed. i.e. 140% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Delta Research Partners LLC" #1 sponsor was "Exact Sciences Corporation" with 9 trials, followed by "Eli Lilly and Company" with 6 trials sponsored, "Galapagos NV" with 4 trials sponsored, "Gilead Sciences" with 4 trials sponsored and "Evoke Pharma" with 4 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Delta Research Partners LLC" #1 collaborator was "Gilead Sciences" with 4 trials as a collaborator, "Premier Research Group plc" with 3 trials as a collaborator, "Allergan Sales, LLC" with 1 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator and "Sucampo Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Delta Research Partners LLC" are "Ulcerative Colitis" (10 trials), "Colorectal Cancer" (8 trials), "Crohn's Disease" (5 trials), "Colonoscopy" (3 trials) and "Diabetic Gastroparesis" (3 trials). Many other conditions were trialed in "Delta Research Partners LLC" in a lesser frequency.

Most popular intervention types in "Delta Research Partners LLC" are "Drug" (32 trials), "Other" (4 trials), "Diagnostic Test" (3 trials), "Device" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Filgotinib" (5 trials), "Mirikizumab" (5 trials), "Andecaliximab" (2 trials) and "Blood Sample Collection" (2 trials). Other intervention names were less common.

The vast majority of trials in "Delta Research Partners LLC" are 40 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Delta Research Partners LLC". undefined are not yet recruiting, 4 are recruiting, 8 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 28 completed trials in Delta Research Partners LLC, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Delta Research Partners LLC, 2 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".